Showing results (21-30 of 78) with videos related to
Sort By:
Pageof 8
BMC Cancer|February 9, 2019
Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasisCarla De Giovanni, Patrizia Nanni, Lorena Landuzzi, et al.NPJ Vaccines|April 27, 2026
HER-2 therapeutic vaccine is not hampered by concurrent HER-2 monoclonal antibodyMaria Sofia Semprini, Chiara Cappello, Laura Scalambra, et al.International Journal of Cancer|March 30, 2006
Insulin-like growth factor binding protein 3 as an anticancer molecule in Ewing's sarcomaStefania Benini, Monia Zuntini, Maria Cristina Manara, et al.Cancers|January 20, 2021
IFN-γ and CD38 in Hyperprogressive Cancer DevelopmentStefania Angelicola, Francesca Ruzzi, Lorena Landuzzi, et al.Proceedings of the National Academy of Sciences of the United States of America|May 22, 2009
Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cellsLaura Menotti, Giordano Nicoletti, Valentina Gatta, et al.Methods in Cell Biology|November 8, 2024
Functional evaluation of circulating anti-cancer antibodies with a 3D tumor cell growth inhibition assayFrancesca Ruzzi, Maria Sofia Semprini, Laura Scalambra, et al.International Journal of Molecular Sciences|August 26, 2023
Virus-like Particle (VLP) Vaccines for Cancer ImmunotherapyFrancesca Ruzzi, Maria Sofia Semprini, Laura Scalambra, et al.European Journal of Cancer (Oxford, England : 1990)|January 28, 2006
Endothelin-3 production by human rhabdomyosarcoma: a possible new marker with a paracrine roleArianna Palladini, Annalisa Astolfi, Stefania Croci, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2002
HER/erbB receptors as therapeutic targets of immunotoxins in human rhabdomyosarcoma cellsCinzia Ricci, Letizia Polito, Patrizia Nanni, et al.Cancer Research|June 5, 2003
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant micePatrizia Nanni, Giordano Nicoletti, Carla De Giovanni, et al.Pageof 8